Discover
NLSP
NLS Pharmaceutics AG
7.62
2 x 0.57
2 x 0.99
bid
ask
+
0.22
2.97%
09:30 AM
| Ytd | -63.89% | |
| 1y | -80.26% |
7.60
day range
8.30
0.76
52 week range
43.40
| Open | 7.70 | Prev Close | 7.40 | Low | 7.60 | High | 8.30 | Mkt Cap | 919.60K |
| Vol | 0.00 | Avg Vol | 74.12K | EPS | -17.40 | P/E | -0.17 | Forward P/E | -3.60 |
| Beta | 0.14 | Short Ratio | 0.15 | Inst. Own | 19.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 18.99 | 200-d Avg | 19.40 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 4.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.07M | ||
| Cash and Equivalents (USD) | 3.07M | ||
| Current Assets | 4.04M | ||
| Property, Plant & Equipment Net | 5.30K | ||
| Total Assets | 4.34M | ||
| Total Liabilities | 1.46M | ||
| Accumulated Retained Earnings (Deficit) | -74.81M | ||
| Accumulated Other Comprehensive Income | 108.85K | ||
| Shareholders Equity | 2.88M | ||
| Shareholders Equity (USD) | 2.88M | ||
| Assets Non-Current | 301.74K | ||
| Trade and Non-Trade Payables | 1.02M | ||